| Autor: |
DeVORE AD; Department of Medicine and Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina. Electronic address: adam.devore@duke.edu., Fonarow GC; Ahmanson-UCLA Cardiomyopathy Center, Ronald Reagan-UCLA Medical Center, Los Angeles, California. |
| Abstrakt: |
Competing Interests: Disclosures Dr. DeVore reports research funding through his institution from Biofourmis, Bodyport, Cytokinetics, American Regent, Inc, the NIH and NHLBI, Novartis, and Story Health. He also provides consulting services for and/or receives honoraria from Bodyport, Cardionomic, LivaNova, Myovant, Natera, NovoNordisk, and Zoll. Dr. Fonarow reports consulting for Abbott, Amgen, AstraZeneca, Bayer, Boehinger Ingelheim, Cytokinetics, Eli Lilly, Johnson & Johnson, sMedtronic, Merck, Novartis, and Pfizer. |
Full Text from ScienceDirect